Empagliflozin treatment differentially modifies visceral and subcutaneous adipose tissue lipidomes and pro-inflammatory cytokines in zucker fatty diabetic rats.

Back

ESC Professional Premium Access

Empagliflozin treatment differentially modifies visceral and subcutaneous adipose tissue lipidomes and pro-inflammatory cytokines in zucker fatty diabetic rats.

Session: Metabolism, mitochondria, and heart diseases

Topic: Metabolism

Speaker: Miss S. Morana Fernandez (Santiago De Compostela, ES)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Miss Sandra Morana Fernandez

Santiago De Compostela (Spain)

0 follower

6 more presentations in this session

Adipose tissue derived ceramides regulate myocardial redox state and predict cardiovascular outcomes

Speaker: Doctor M. Polkinghorne (Oxford, GB)

Access

Abstract

Slides

Oleoylethanolamide mitigates cardiac metabolic alterations secondary to obesity induced by high-fat diet in C57/BL6J mice

Speaker: Miss F. Comella (Naples, IT)

Access

Abstract

Slides

BNIP3 regulates cardiac energy metabolism by interaction with F1FO ATP-synthase

Speaker: Ms A. Beerlage (Essen, DE)

Access

Abstract

Slides

Chronic insulin resistance deteriorates cardiac mitochondrial quality control in a mouse model of SEC-NAFLD-IR

Speaker: Doctor K. Lu (Duesseldorf, DE)

Access

Abstract

Slides

Myocardial inflammation in ischaemic and non-ischaemic heart failure relates to impaired mitochondria

Speaker: Mr J. Borger (Duesseldorf, DE)

Access

Abstract

Slides

Access the full session

Metabolism, mitochondria, and heart diseases

Speakers: Miss S. Morana Fernandez, Doctor M. Polkinghorne, Miss F. Comella, Ms A. Beerlage, Doctor K. Lu...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources